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Background: Studies on the influence of alcohol consumption on lung function have shown con-
flicting results. Self-reported alcohol consumption may be inaccurate. This study used both a
validated alcohol questionnaire and a blood marker of heavy alcohol consumption, and exam-
ined potential associations with different lung physiological variables.
Methods: The study population (450 subjects) answered an alcohol questionnaire (AUDIT-C)
and performed spirometry, body plethysmography and a test for diffusing capacity for CO
(DL,CO). Carbohydrate deficient transferrin (CDT), a clinically used blood marker for identifying
heavy alcohol consumption, and C-reactive protein (CRP), a marker of systemic inflammation
were analysed.
Results: Using AUDIT-C, 407 subjects were alcohol drinkers and 29 non-drinkers. Of the alcohol
drinkers, 224 subjects were “hazardous drinkers” and 183 “moderate drinkers”. Thirty-four
subjects had a CDT 2.0% (Zheavy drinkers). There was no difference in lung function be-
tween hazardous and moderate drinkers. Heavy drinkers had lower DL,CO (74% vs 83% PN,
p Z 0.003), more symptoms of chronic bronchitis (p Z 0.001) and higher AUDIT-C scores
(p < 0.001) than non-heavy drinkers. After adjustments (pack years and CRP) the difference
in DL,CO (p Z 0.037) remained. Multiple regression showed an association between CDT and
both FEV1 (p Z 0.004) and DL,CO (p Z 0.012) in all alcohol drinkers, but not in never-0 338733; fax: þ46 40 338768.
d.lu.se (S. Frantz).
3 Elsevier Ltd. All rights reserved.
13.08.041
Lung function and alcohol consumption 115smokers. The AUDIT-C score was associated with CDT (also after adjustments, p < 0.001) but
not with any lung function variable.
Conclusion: The results from this study suggest that alcohol and particularly heavy drinking has
an independent additive negative effect on lung function in smokers.
ª 2013 Elsevier Ltd. All rights reserved.Introduction
The effects of alcohol consumption on lung function are
still not completely clarified, even though several studies
have been performed over the last decades [1e5]. Large,
population-based studies have shown no effect at all of
alcohol on lung function [6,7] or COPD (chronic obstructive
pulmonary disease) mortality [4] as well as a negative ef-
fect of high alcohol consumption on lung function [5,8].
Also positive effects on lung function by light to moderate
drinking, compared to abstaining from alcohol has been
reported [9]. Some studies showed abnormal lung function
among high consumers of alcohol recruited in hospital
settings [1,2,10]. Most studies have measured forced expi-
ratory volume in one second (FEV1) and vital capacity (VC)
by spirometry as the only tests of lung function [5,7,8].
For alcohol consumption, most studies in this field have
used self-reported information [5,11], which could be
subject to recall bias [12]. A previous study used g-gluta-
myltranspeptidase (GGT) instead, a biological marker of
drinking, and found a negative association between FEV1
and alcohol consumption [13]. Carbohydrate deficient
transferrin (CDT) is another, and compared with GGT a
more sensitive and specific serum marker of elevated
alcohol consumption [14,15]. A previous study in a smaller
group of COPD patients showed an inverse correlation be-
tween CDT and FEV1 [16]. That study did not include any
questions about alcohol consumption, however.
The objective of this study was to examine potential
effects of alcohol consumption on lung function, after ad-
justments for potential confounders including pack years
and C-reactive protein (CRP) in a population-based group of
subjects by using both a validated questionnaire (AUDIT-C)
and a clinically used specific alcohol blood marker and
conducting lung physiological assessments at a specialised
centre.
Methods
This was a cross sectional study including one clinic visit
performed at the Department of Clinical Physiology, Malmo¨
University Hospital (UMAS) in Malmo¨ between June 2004
and May 2007.
Study population
The invited study population consisted of 870 subjects, who
comprised a sub-population from a postal respiratory
questionnaire survey (“Questions about the lungs”) per-
formed in a random population sample in 1992 as well as
2000 [17]. For the current study, three different groups of
subjects, all residing in the area of Malmo¨, southern Swe-
den, were recruited from the previous study; (1) subjectswho did not report any respiratory symptoms and never had
smoked (n Z 120) (2) subjects who did not report any
respiratory symptoms and were current smokers (n Z 560)
(3) subjects who responded that they had or had a diagnosis
of chronic bronchitis or emphysema or COPD (n Z 190). At
the study visit, subjects were classified according to their
current smoking habits (current smokers, ex-smokers and
never smokers) and spirometry results according to the
GOLD 2010 criteria. The recruitment process is described in
more detail elsewhere [18].Ethics approval
The study was approved by the Ethics Committee of Lund
University and participants signed an informed consent
before any study related procedure.Questionnaires
Questions about the lungs
This questionnaire was used both for study recruitment
purposes and at the study visit. “Questions about the lungs”
is a questionnaire about respiratory diseases and symptoms
that has been used in several previous surveys and is
described elsewhere [19].
Chronic bronchitis, chronic cough and pulmonary
medication
A positive answer to “Have you had periods of 3 months
with cough with phlegm during 2 years in a row sometimes
during the last years?” was interpreted as a report of
chronic bronchitis. The question “Have you had long-
standing cough during the last 12 months?” was used to
identify longstanding cough. Use of pulmonary medication
was assessed by the item “Do you regularly take or have
taken any pulmonary medication?”.
AUDIT-C
The Alcohol Use Disorders Identification Test (AUDIT) is a
validated questionnaire for examining drinking habits [20].
The three alcohol consumption questions (AUDIT-C) from
this test is a brief screening test for problem drinking [20].
The AUDIT-C questions and their scores are:
1. How often do you have a drink containing alcohol?
(Never (0 points), Monthly or less (1 points), Two to four
times a month (2 points), Two to three times a week (3
points), Four or more times a week (4points)).
2. How many drinks containing alcohol do you have on a
typical day when you are drinking?
(1 or 2 (0 points), 3 or 4 (1 points), 5 or 6 (2 points), 7 to 9
(3 points), 10 or more (4 points)).
3. How often do you have six or more drinks on one
occasion?
116 S. Frantz et al.(Never (0 points), Less than monthly (1 points), Monthly
(2 points), Weekly (3 points), Daily or almost daily (4
points)).
The total AUDIT-C score is the sum of scores for the 3
questions resulting in possible total AUDIT-C scores from
0 to 12.
The first question in AUDIT-C “How often do you have a
drink containing alcohol?” was used to identify non-
drinkers. Subjects that had not answered the first ques-
tion in AUDIT-C were excluded from further analyses. The
total score of AUDIT-C (ranging from 0 to 12) was used to
discriminate between moderate and hazardous drinking.
For women a total score on AUDIT-C 3 was regarded as
hazardous drinking and for men 4 [21].
Carbohydrate deficient transferrin (CDT)
CDT was analyzed in serum by the high-performance liquid
chromatography (HPLC) method [22]. CDT is expressed as
the percentage of transferrin being carbohydrate deficient,
a share that is increased by heavy alcohol consumption. The
level of CDT reflects the alcohol consumption of the last
1e3 weeks. CDT was used to identify subjects with heavy
alcohol consumption. Similarly to clinical practice a value
of 2.0% was used for identifying subjects with heavy
alcohol consumption in the study [23] hsCRP.
High-sensitivity C-reactive protein (hsCRP) was
measured in serum by an IMMAGE rate nephelometer,
BeckmaneCoulter, Brea, CA, USA. The detection limit was
0.2 mg/l with imprecision 9% (coefficient of variation)at
1.0 mg/l, 7% at 13.0 mg/l and 7% at 75.0 mg/1.
Smoking habits
Subjects who currently smoked or had stopped within the
last 12 months prior to the investigation were classified as
current smokers. Ex-smokers were subjects who had
stopped smoking more than 12 months prior to the inves-
tigation. Subjects who never had been smoking daily for at
least one month were classified as never-smokers. For
subjects being current smokers or ex-smokers, the term
ever-smokers were used. The total tobacco consumption
was calculated in pack years.
Lung function testing
Both spirometry and body plethysmography were per-
formed according to European Respiratory Society (ERS)
recommendations [24], and European reference values
were used [24] as previously described [18]. Diffusing ca-
pacity for CO (DL,CO)was measured using the single-breath
technique [25], Master Screen, Viasys GmbH e Erich
Jaeger) also as previously described [18].
Classification and staging of COPD
COPD was diagnosed according to the GOLD (Global initia-
tive for chronic Obstructive Lung Disease) criteria (http://
www.goldcopd.org, version 2010), based on a post-
bronchodilator FEV1/VC ratio < 0.7. Also staging of COPD
severity was performed according to the GOLD criteria(version 2010) with stage I (mild): FEV1  80% of predicted
normal (PN), stage II (moderate): 50%  FEV1  80% PN,
stage III (severe): 30%  FEV1  50% PN, and stage IV (very
severe COPD): FEV1 < 30% PN.
Statistical analyses
IBM SPSS Statistics 20 (SPSS Inc. Chicago, Illinois 60606 was
used for the statistical analyses. One-way ANOVA was used
for comparisons of continuous variables between groups.
Continuous variables not normally distributed (CDT, CRP
and current daily tobacco consumption) were log-
transformed before the analyses. Categorical variables
were compared using Chi-square analysis. Multivariate
linear regression analyses of crude lung function variables
with adjustments for age, sex, weight and height in the first
step and addition of pack years and CRP in a second step
was used to analyse the influence of the different alcohol
drinking categories as well as CDT on lung function vari-
ables. Adjustments were made for age, sex, weight and
height in the first step and then also for pack years and CRP.
A p-value of <0.05 was considered statistically significant.
Results
Characteristics of the study population
Of the 870 invited subjects, 450 subjects (52%) partici-
pated. Participation rates for never-smokers not reporting
COPD, current smokers not reporting COPD and subjects
reporting COPD were 50% (n Z 60), 50% (n Z 282) and 57%
(n Z 108), respectively.
Fourteen subjects were excluded from further analyses
because they had not answered AUDIT-C and then could not
be classified as non-drinkers or alcohol drinkers. The final
study groups are described in Fig. 1a and b.
Table 1 shows the general characteristics and Table 2
shows the lung function and respiratory symptoms of the
alcohol drinking part of the study population divided in two
different ways e into moderate and hazardous alcohol
drinkers according to AUDIT-C (n Z 407) (Fig. 1a) and into
non-heavy and heavy alcohol drinkers according to CDT
(n Z 401) (Fig. 1b).
Comparisons of moderate and hazardous drinkers
vs non-heavy and heavy drinkers
Comparisons between moderate and hazardous drinkers
(according to the AUDIT-C definitions) showed statistically
significant differences in age and smoking habits (Table 1).
Hazardous drinkers were younger, had more pack years,
and in addition were more often current smokers. There
were no significant differences between hazardous and
moderate drinking regarding any of the lung function vari-
ables or respiratory symptoms. Levels of CDT were higher
among hazardous compared with moderate drinkers (1.48,
vs 1.11, p < 0.001).
Comparisons between non-heavy and heavy drinkers
(according to CDT; Tables 1 and 2) showed that heavy
drinking was associated with more pack years and current
Figure 1 (a). Flow chart demonstrating the classification of
participants depending on their alcohol consumption in non-
drinkers, moderate and hazardous drinkers according to
AUDIT-C. (b). Flow chart demonstrating the classification of
participants depending on their alcohol consumption in non-
drinkers according to AUDIT-C, and non-heavy and heavy
alcohol drinkers according to CDT.
Lung function and alcohol consumption 117smoking. Not seen for hazardous drinkers though, heavy
drinking was associated with male gender and lower BMI as
well as with lower FEV1/VC and DL,CO. Heavy drinkers more
often had COPD according to the GOLD criteria and more
often reported respiratory symptoms.
In Table 3 the different alcohol drinking groups are
compared concerning lung function. For hazardous and
moderate drinkers, no differences were seen, neither with
nor without adjustments for pack years and CRP. For heavy
and non-heavy drinkers a significant difference was seen for
DL,CO, both when adjusted for age, sex, height and weight
and after additional adjustments for pack years and CRP.
Then the continuous associations between CDT and lung
function and other potential influencing factors were
investigated. After adjusting the crude lung function vari-
ables for age, sex, height and weight, a higher CDT was
associated with lower FEV1, VC, FEV1/VC and DL,CO. The
associations between CDT and FEV1 and DL,CO remained also
after additional adjustments for pack years and CRP. All
analyses of DL,CO were made with and without adjustment
for haemoglobin, and no significances were changed (not
shown).
Results of the multiple linear regression analyses with
FEV1 and DL,CO as target variables for each of the four alcohol
drinking categories are shown in Table 4. This was also per-
formed in drinkers who were never-smokers and in ever-
smokers, respectively. In all groups except never-smoking
drinkers, CDT was statistically significantly associated with
a decrease in FEV1 and in ever-smoking drinkers, hazardous
drinkers and heavy drinkers also with a decrease in DL,CO.AUDIT-C was associated with CDT (also after adjustment
for confounders, rZ 0.344 and p < 0.001) but not with any
lung function variable (not shown).Discussion
This study found an association between higher level of the
blood marker CDT and lower FEV1 and DL,CO among subjects
reporting any alcohol consumption on AUDIT-C, also after
adjustments for potential confounders including tobacco
consumption (pack years) and systemic inflammation (CRP).
These results may suggest that alcohol and particularly
heavy drinking has an independent negative effect on lung
function.
To our knowledge there is no previously published study
on associations between lung function and alcohol con-
sumption that has assessed alcohol consumption by both
self-report, using the validated questionnaire AUDIT-C as
well as by the blood marker, CDT, considered to be specific
for identifying heavy alcohol consumption. CDT is likely to
provide a more reliable identification of subjects with
chronic heavy alcohol consumption than a questionnaire
[12]. Questionnaires are an established tool especially in
primary care to identify subjects with hazardous alcohol
consumption. In this study, four subjects with elevated CDT
illustrate the difference between self-reported consump-
tion as retrieved from a questionnaire and a biomarker, in
giving information in AUDIT-C classifying them as moderate
drinkers. CDT is a biomarker rather reflecting biological
effects of alcohol consumption. With AUDIT-C, subjects are
categorised as hazardous or moderate drinkers on the basis
of amount and frequency of alcohol intake. The alcohol
consumption required to raise CDT above 2% appears to be
considerably larger than that to be classified as hazardous
drinker by AUDIT-C [26]. It is therefore expected that the
number of heavy drinkers identified with CDT will be
smaller than the number of hazardous drinkers identified by
AUDIT-C [27].
The most common and important risk factor for
decreased lung function is smoking, and smoking is more
common among high consumers of alcohol [10]. Therefore
it is an important pre-requisite to obtain detailed infor-
mation about smoking habits in studies on alcohol and lung
function [4,5]. The population in this study was recruited
based on their smoking habits, explaining the large number
of ever-smokers (see Methods).
There were no significant differences in lung function
between hazardous and moderate drinking according to
AUDIT-C, but lung function was lower in subjects with
elevated CDT compared with the rest of subjects who re-
ported any alcohol consumption (non-heavy drinkers). A
multivariate linear regression also showed a significant as-
sociation between increase in CDT and decrease in lung
function. Nihle´n et al. [16] found an association between a
diagnosis of COPD and a higher level of CDT and among
COPD patients. In that study, a lower FEV1 was associated
with higher CDT. The focus of that study was not the rela-
tionship between alcohol consumption and pulmonary
function, and no self-reported information on alcohol
consumption was available. The reason behind the associ-
ation between a higher CDT and lower lung function
Table 1 Characteristics of the alcohol drinking part of the study population, divided into moderate drinkers and hazardous
drinkers based on their total score of AUDIT-C, and into non-heavy drinkers and heavy drinkers based on their CDT levels. The
selection of the final study groups is described in Fig. 1a and b.
AUDIT-C classification (n Z 407) CDT classification (n Z 401)
Moderate
drinkers
(n Z 183)
Hazardous
drinkers
(n Z 224)
p-Value Non-heavy
drinkers
(CDT  2.0%)
(n Z 367)
Heavy
drinkers
(CDT>2.0%)
(n Z 34)
p-Value
Women 62% (113) 54% (122) 0.168 60% (219) 29% (10) 0.001
Age (years) 62.9 (46e78) 60.1 (46e77) <0.001 61.2 (46e78) 63.4 (53e77) 0.097
BMI (kg/m2) 26.6 (18e44) 26.1 (17e45) 0.341 26.5 (17e45) 24.1 (18e31) 0.007
CRP (mg/l) 3.66 (0.1e25.6) 3.06 (0.1e21.5) 0.083 3.25 (0.1e26) 4.04 (0.5e22) 0.076
Ever-smokers 73% (134) 87% (194) 0.001 79% (291) 94% (32) 0.062
Current smokers 39% (72) 55% (124) 0.002 45% (165) 85% (29) <0.001
Pack years 19.6 (0e110) 24.7 (0e135) 0.008 21.3 (0e115) 34.7 (0e135) <0.001
Current daily
tobacco consumption
(number of cigarettes)
4.7 (0e54) 8.0 (0e55) 0.029 5.9 (0e55) 14.0(0e35) 0.057
CDT (%) 1.11 (0.3e3.8) 1.48 (0.6e8.0) <0.001 1.16(0.3e1.9) 3.02(2.0e8.0) <0.001
AUDIT-C total score 1.75 (1e3) 4.63 (3e12) <0.001 3.14(1e9) 5.59(1e12) <0.001
AUDIT Q1: How often
do you have a drink
containing alcohol?
1.54 (1e3) 2.77 (1e4) <0.001 2.15 (1e4) 3.03 (1e4) <0.001
AUDIT Q2: How many
drinks containing
alcohol do you have
on a typical day
when you are drinking?
0.08 (0e1) 0.72 (1e4) <0.001 0.40 (0e4) 0.79 (0e4) 0.001
AUDIT Q3: How often
do you have six or
more drinks on
one occasion?
0.14 (0e1) 1.14 (1e4) <0.001 0.59 (0e3) 1.76 (0e4) <0.001
Continuous values are presented as means and ranges. Categorical variables are presented as percentage (n). BMI Z body mass index.
Q Z question. For more information on scoring in AUDIT-C, see Methods.
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that there are dose-dependent, detrimental effects of
alcohol on lung function. Only one of the heavy drinkers
reported treatment with inhaled medications. This could be
due to the fact that heavy drinkers are visiting the health
care system more seldom despite respiratory disease or
poor adherence to prescribed medications, or both. It may
also be that heavy drinkers in our study did not adequately
report their use of medications. Lung function was
measured as a post-bronchodilator value, which would
minimize the effect of the low frequency of inhaled med-
ications among heavy drinkers in this study.
Recall bias and inaccuracy in the reporting of alcohol
consumption may partly explain why no associations were
observed between lung function and AUDIT-C. This can
perhaps also explain why some previous studies [6,7] did not
find any association between high alcohol consumption and
decrease in lung function after adjustment for smoking
habits. These studies have used self-reported information on
alcohol consumption only and lung function measurements
were restricted to spirometry. There are, however, also
large, community-based studies that indicate an indepen-
dent, negative effect of alcohol intake on lung function[5,13,28]. Case-control studies have also shown heavy
drinkers to have lower lung function than moderate drinkers
[1,2,10].
Our study adds new aspects on the relation between
alcohol consumption and lung function. To the best of our
knowledge, this is the first large, community-based study
that has included measurement of DL,CO. The difference in
DL,CO between the groups of heavy and non-heavy drinkers
was significant, which was not the case for FEV1. This sug-
gests that DL,CO is a more sensitive indicator of the effects
of alcohol on the lungs. Peavy et al. showed in a previous
study [29] an acute, negative effect on DL,CO 60 min after
alcohol ingestion. Another study [2] showed that former
alcoholics had higher DL,CO than current alcoholics, indi-
cating that a low DL,CO because of heavy alcohol con-
sumption is something that can be affected positively by
abstinence. The mechanism remains unknown, but appears
not to be caused by a difference in haemoglobin concen-
tration. The relation between alcohol consumption and CRP
has been found to be U-shaped with the lowest values
among moderate drinkers [26]. In our study we did not
observe such a U-shaped relationship. In addition CRP is
well known to be increased in smokers and also in COPD,
Table 2 Lung function and respiratory symptoms of the alcohol drinking part of the study population, divided into moderate
drinkers and hazardous drinkers based on their total score of AUDIT-C, and into non-heavy drinkers and heavy drinkers based on
their CDT levels. The selection of the final study groups is described in Fig. 1a and b.
AUDIT-C classification (n Z 407) CDT classification (n Z 401)
Moderate
drinkers
(n Z 183)
Hazardous
drinkers
(n Z 224)
p-Value Non-heavy
drinkers
(CDT  2.0%)
(n Z 367)
Heavy
drinkers
(CDT > 2.0%)
(n Z 34)
p-Value
FEV1 (% of PN) 100 (19) 100 (16) 0.996 100(17) 96(20) 0.113
VC (% of PN) 111 (16) 110 (15) 0.562 111 (15) 109(18) 0.392
FEV1/VC (% of PN) 96 (12) 96 (11) 0.686 96 (11) 92(13) 0.033
TLC (% of PN) 104 (12) 103 (12) 0.477 104 (12) 103(13) 0.648
RV (% of PN) 108 (21) 106 (21) 0.391 107 (21) 108(30) 0.778
DL,CO (% of PN) 82 (17) 83 (16) 0.596 83 (16) 74(20) 0.003
COPD (n) 30% (54) 29% (64) 0.922 27% (99) 50% (17) 0.008
COPD stage I (n) 21% (38) 19% (42) 0.701 19% (68) 29% (10) 0.191
COPD stage II-IV (n) 9% (16) 10% (22) 0.841 8% (31) 23% (7) 0.045
Symptoms of CB 10% (18) 16% (33) 0.152 11% (39) 37% (11) 0.001
Long-standing cough 18% (32) 19% (42) 0.765 17% (61) 40% (12) 0.012
Any use of pulmonary
medication
8% (15) 10% (21) 0.782 10% (35) 3% (1) 0.339
Continuous values are presented as means and standard deviations. Categorical variables are presented as percentage (n). TLCZ total
lung capacity, RV Z residual volume, CB Z chronic bronchitis.
Lung function and alcohol consumption 119probably due to a systemic inflammation [30]. CRP was used
in our analyses to adjust for potential residual confounding
effects of smoking.
A practical clinical consequence of the results of this
study could be that lung function testing, including DL,CO,
may be recommended in subjects with increased CDT.
Further studies may be valuable to examine whether there
likewise would be a threshold or not also for the AUDIT-C
score above which lung function testing should be
considered.Table 3 Relationship between alcohol consumption and lung f
analyses.
FEV1 (l) VC (l) FEV1/VC
Hazardous vs
moderatea
0.008 (0.050)
p Z 0.875
0.004 (0.052)
p Z 0.933
0.034 (0.8
p Z 0.970
Hazardous vs
moderateb
0.023 (0.047)
p Z 0.628
0.012 (0.052)
p Z 0.816
0.608 (0.86
p Z 0.484
Heavy vs
non-heavya
0.170 (0.089)
p Z 0.058
0.038 (0.094)
p Z 0.686
2.963 (1.5
p Z 0.064
Heavy vs
non-heavyb
0.065 (0.086)
p Z 0.450
0.036 (0.094)
p Z 0.698
1.756 (1.5
p Z 0.263
CDTa 0.287 (0.071)
p < 0.001
0.205 (0.075)
p Z 0.007
3.231 (1.2
p Z 0.012
CDTb 0.201 (0.069)
p Z 0.004
0.145 (0.076)
p Z 0.057
2.259 (1.2
p Z 0.075
Values are unstandardized B coefficients (standard error, SE). For the
the B coefficient represents the change after increase of 1 standard
a Adjusted for sex, age, height and weight.
b In addition adjusted for pack-years and CRP.An interesting question, not addressed in this study,
is whether there may be any negative effect of
abstaining from alcohol, which has been suggested in
some studies [9,31]. In this study, the non-drinkers were
few (n Z 29) and not included in the statistical ana-
lyses. For this reason this study can not evaluate
whether moderate alcohol consumption may be benefi-
cial compared to abstaining. A larger, well defined
sample of non-drinkers would be necessary to study this
potential phenomenon.unction variables according to multivariate linear regression
TLC (l) RV (l) DL,CO
(mmol/kPa/min)
90) 0.036 (0.072)
p Z 0.621
0.036 (0.046)
p Z 0.436
0.070 (0.141)
p Z 0.621
8) 0.050 (0.072)
p Z 0.490
0.059 (0.046)
p Z 0.199
0.002 (0.133)
p Z 0.985
94) 0.011 (0.130)
p Z 0.929
0.045 (0.083)
p Z 0.587
0.833 (0.251)
p Z 0.001
67) 0.052 (0.130)
p Z 0.693
0.034(0.083)
p Z 0.686
0.501 (0.239)
p Z 0.037
81) 0.185 (0.104)
p Z 0.077
0.027 (0.067)
p Z 0.684
0.780 (0.202)
p < 0.001
67) 0.131 (0.106)
p Z 0.214
0.020 (0.068)
p Z 0.764
0.489 (0.193)
p Z 0.012
continuous relationship between CDT and lung function variables,
deviation of lnCDT.
Table 4 Summary of relationships between CDT and FEV1 and DL,CO respectively, in different alcohol consumption categories
according to multivariate linear regression analyses. Adjustments have been made for sex, age, height, weight, pack years and
CRP. Unstandardized B coefficients and p-values are shown.
Target
variable
Alcohol
variable
Moderate
drinkers
(n Z 183)
Hazardous
drinkers
(n Z 224)
Non-heavy
drinkers
(n Z 367)
Heavy
drinkers
(n Z 34)
Never-smoking
drinkers
(n Z 79)
Ever-smoking
drinkers
(n Z 328)
FEV1 CDT 0.373
p Z 0.015
0.221
p Z 0.020
0.261
p Z 0.029
0.837
p Z 0.020
0.015
p Z 0.944
0.218
p Z 0.003
DL,CO CDT 0.211
p Z 0.614
0.759
p Z 0.006
0.233
p Z 0.484
2.149
p Z 0.041
0.741
p Z 0.180
0.568
p Z 0.007
120 S. Frantz et al.This study has some other important limitations. Ele-
vated alcohol consumption is closely associated with
smoking [32]. It can not be excluded that residual con-
founding by smoking may have influenced at least partly
the results despite adjustments for smoking in the sta-
tistical analyses. Additional analyses did not show any
associations between CDT (or AUDIT-C total score) and
lung function variables in never-smokers (n Z 79). This
observation indicates that the found associations are
applicable in ever-smokers only and may be attributable
to additive effects of alcohol and smoking. The back-
ground to such effects is unknown, but it is known that
alcohol has a lot of different detrimental effects also
affecting lung tissue [33]. In comparison with most
epidemiological studies, the study population is limited.
The number of heavy drinkers was small why the results
should be interpreted with some caution. Another limi-
tation is that because of this we have not had the pos-
sibility to compare the results for alcohol drinkers with a
large, well-defined group of non-drinkers.
In conclusion, this study showed an association be-
tween higher CDT and lower FEV1, as well as DL,CO, in
subjects drinking alcohol, also after adjustments for po-
tential confounders. No such associations were observed
in never-smokers, however. Together with the observed
statistically significant relationship between the AUDIT-C
score and the level of CDT this result suggests that
increasing alcohol consumption has a negative effect on
lung function at least in smokers and that the negative
effects of alcohol is additive to that of smoking. Further
studies are needed to examine the mechanisms behind
these results.
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